← Back to Patent Explorer
US3232836A Expired / Lapsed US ⏱️ 0.0 years remaining

Facilitating healing of body surface wounds by intravenous administration of n-acetyl glucosamine, glucosamine, or pharmaceutically acceptable acid salts of glucosamine

Assignee: Pfizer Inc
•
Filing: 1959-08-24
•
Granted: 1966-02-01
•
Expires: 1979-08-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

No abstract record available.

Inventors

  • 👤 Carlozzi Michael
  • 👤 Domenic G Iezzoni

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-22 22:10
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/7004

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 42 words
A PROCESS FOR FACILITATING HEALING OF A WOUND OF THE BODY SURFACE WHICH COMPRISES ADMINISTERING INTRAVENOUSLY FROM ABOUT 100 TO ABOUT 200 GRAMS OF A COMPOUND SELECTED FROM THE GROUP CONSISTING OF N-ACETYL GLUCOSAMINE, GLUCOSAMINE AND PHARMACEUTICALLY ACCEPTABLE ACID SALTS OF GLUCOSAMINE.
Claim 2
Dependent Claim 42 words
A PROCESS FOR FACILITATING HEALING OF A WOUND OF THE BODY SURFACE WHICH COMPRISES ADMINISTERING INTRAVENOUSLY FROM ABOUT 100 TO ABOUT 200 GRAMS OF A COMPOUND SELECTED FROM THE GROUP CONSISTING OF N-ACETYL GLUCOSAMINE, GLUCOSAMINE AND PHARMACEUTICALLY ACCEPTABLE ACID SALTS OF GLUCOSAMINE.

References Cited (Backward Citations)

US2832766A Cited
US2786051A Cited
US2710806A Cited
US2802819A Cited
US2884411A Cited
US2910408A Cited
US2980584A Cited
US2997471A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1969-01-31 1969-08-02 1970-02-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1973-01-31 1973-08-02 1974-02-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1977-01-31 1977-08-02 1978-02-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag